Ledger.Open graph →
SEC Form D · Amendment · filed December 31, 2025

Alpenglow Biosciences, Inc

Offering
$3.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Michael T. Dutton · Seattle, WAExecDaniella T. Kranjac · Seattle, WADirectorJonathan T. Liu · Seattle, WADirectorNicholas P. Reder · Seattle, WAExec · DirectorDaniella T. Kranjac · Seattle, WADirectorMichael T. Dutton · Seattle, WAExecJonathan T. Liu · Seattle, WADirectorNicholas P. Reder · Seattle, WAExec · DirectorJames Watt · Houston, TXDirectorWilliam Robertson · Houston, TXExecGregg Williams · Bozeman, MTDirectorNicolas De Castro · BOZEMAN, MTExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗